A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

October 7, 2021

Primary Completion Date

June 15, 2023

Study Completion Date

October 30, 2025

Conditions
Multiple Myeloma
Interventions
DRUG

Elranatamab

BCMA-CD3 bispecific antibody

Trial Locations (51)

10002

National Taiwan University Hospital, Taipei

10021

Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York

10065

Memorial Sloan Kettering Cancer Center, New York

10604

MSK Westchester, Harrison

11101

Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy, Long Island City

11217

Taipei Veterans General Hospital, Taipei

11553

MSK Nassau, Uniondale

11725

MSK Commack, Commack

19111

Fox Chase Cancer Center, Philadelphia

32608

UF Health Shands Cancer Hospital, Gainesville

32610

UF Health Shands Hospital Pharmacy Investigational Drug Service - Main, Gainesville

UF Health Shands Hospital, Gainesville

32611

University of Florida, Gainesville

40447

China Medical University Hospital, Taichung

44195

Cleveland Clinic Taussig Cancer Institute, Cleveland

48109

The Regents of the University of Michigan, Ann Arbor

University of Michigan, Ann Arbor

48202

Henry Ford Hospital, Detroit

70006

East Jefferson General Hospital Bone Marrow Transplant Clinic, Metairie

East Jefferson General Hospital, Metairie

70112

Tulane University, New Orleans

78229

Blood Cancer and Stem Cell Transplant Clinic, San Antonio

Methodist Healthcare System of San Antonio dba Methodist Hospital, San Antonio

Methodist Hospital Investigational Pharmacy, San Antonio

Methodist Plaza Clinical Trials Office, San Antonio

78704

St. David's South Austin Medical Center, Austin

78745

Texas Oncology - South Austin, Austin

80524

Poudre Valley Hospital, Fort Collins

80528

Cancer Care & Hematology - Fort Collins, Fort Collins

Poudre Valley Health System (PVHS), Fort Collins

80538

UCHealth Cancer Care & Hematology - Loveland, Loveland

80634

UCHealth Cancer Care & Hematology - Greeley, Greeley

84112

Huntsman Cancer Institute, University of Utah, Salt Lake City

University of Utah, Salt Lake City

85054

Mayo Clinic Hospital, Phoenix

85259

Mayo Clinic, Scottsdale

07920

MSK Basking Ridge, Basking Ridge

07748

MSK Monmouth, Middletown

07645

MSK Bergen, Montvale

467-8602

Nagoya City University Hospital, Nagoya

650-0047

Kobe City Medical Center General Hospital, Kobe

104-0045

National Cancer Center Hospital, Chuo-ku

150-8935

Japanese Red Cross Medical Center, Shibuya-ku

602-8566

University Hospital,Kyoto Prefectural University of Medicine, Kyoto

B15 2TH

University Hospitals Birmingham NHS Foundation Trust, Birmingham

NW1 2PG

University College London Hospitals NHS Foundation Trust, London

SE1 9RT

Guy's and St Thomas' NHS Foundation Trust, London

SE5 9RS

King's College Hospital NHS Foundation Trust, London

SW3 6JJ

The Royal Marsden NHS Foundation Trust, London

W1T 7HA

University College London Hospitals NHS Foundation Trust NIHR, London

SM2 5PT

The Royal Marsden NHS Foundation Trust, Surrey

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY